PAOG Publishes 2021 Cannabis Biopharmaceutical Strategic Outlook
Sandusky, OH, January 14, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today published a management outlook for 2021 on the company’s strategy to develop and monetize the cannabis assets acquired last year. The strategic outlook is included in its entirety below: PAOG 2021 Cannabis Biopharmaceutical Strategic Outlook PAOG is
PAOG Confirms Cannabis Biopharmaceutical Strategic Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021
Sandusky, OH, January 12, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today confirmed an update covering the company’s 2021 cannabis pharmaceutical and nutraceutical development outlook is scheduled this Thursday Jan 14th, 2021. In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC PINK: PURA) and RespRx from Kali-Extracts,
Nutra Pharma Letter to Shareholders
Plantation, Florida, January 12, 2021 — OTC PR WIRE — Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today that the Company’s
PAOG Cannabis Pharmaceutical and Nutraceutical 2021 Strategy Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021
Sandusky, OH – January 11, 2021 – PAO Group, Inc. (OTC PINK: PAOG) today announced an update covering the company’s 2021 cannabis pharmaceutical and nutraceutical development outlook is scheduled this Thursday Jan 14th, 2021. In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC PINK: PURA) and RespRx from Kali-Extracts, Inc. (OTC
PAOG Confirms Q4 2020 Revenue From Cannabis Asset Acquisition
Sandusky, OH, January 8, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today confirmed that the company expects to realize and report in Q4 2020 the first revenue from assets acquired in the course of 2020. In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC PINK: PURA)
PAOG Takes Major CBD Pharmaceutical Development Step Forward
Sandusky, OH, January 5, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced a major step forward in the development of a CBD pharmaceutical product. PAOG today announced an engagement with Veristat, Inc., a contract research organization headquartered in Southborough Massachusetts. PAOG has engaged Veristat to assist in advancing
PAOG Expects To Report First Post Acquisition Revenue In Q4 2020
Sandusky, OH, December 22, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today announced that the company expects to realize and report in Q3 2020 the first revenue from assets acquired in the course of 2020. In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC PINK: PURA) and
PAOG Develops CBD Nutraceutical For $12.7 Billion Market From Patented Extract Process
Sandusky, OH, December 18, 2020 – OTC PR WIRE – PAO Group, Inc. (OTC US: PAOG) today announced the company expects to generate its first revenue next year in 2021 from its Cannabidiol (CBD) extraction technology, RespRx, acquired in July of this year, 2020. Yesterday, PAOG announced an engagement with the Puerto Rico Consortium
PAOG Announces Puerto Rico Consortium For Clinical Investigation Engagement To Advance CBD COPD Nutraceutical Care Solution
Sandusky, OH, December 17, 2020 – OTC PR WIRE — PAO Group, Inc. (OTC US: PAOG) today announced an engagement with the Puerto Rico Consortium for Clinical Investigation to assist PAOG with developing its proprietary Cannabidiol (CBD) extract into a nutraceutical product to provide care for those experiencing issues associated with Chronic Obstructive Pulmonary
Contact Us
- 707-OTC-WIRE (707-682-9473)
- cs@otcprwire.com
Recent Comments